Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2012 Biotech Charity Contest -- Ignore unavailable to you. Want to Upgrade?

To: BulbaMan who wrote (382)	11/12/2012 10:06:33 AM
From: ghmm	1 Recommendation Respond to of 513

The Abraxane Pancreatic news should lock it for rkrw and put biomavin at a solid #2. My congrats and thanks to both. I didn't buy a lot but enough and quite health returns. Will be happy to donate to his charity!

To: BulbaMan who wrote (382)	11/16/2012 5:10:27 PM
From: BulbaMan	Read Replies (2) \| Respond to of 513

11/16/12 Contest Update Pissed off at Obama’s reelection, the 1% dumped their stocks. Plus, they began taking profits before next year’s tax hike. There are surely other reasons for the post-election stock market slide, but my gut goes for these two. At Friday’s close, the Contest median was up 14.30% YTD (vs. up 20.84% YTD a week ago). In comparison, the Nasdaq Biotech Index actually gained for the week and was up 26.42% YTD (vs. up 24.99% YTD a week ago), while the Nasdaq Composite Index was up 9.52% YTD (vs. up 11.50% YTD a week ago). Although it included two of the week’s worst performing stocks (TZYM, ISR), RKRW’s portfolio, up 116.73% YTD, got enough of a boost from CELGZ to show a gain for the week. And it continued to hold a large lead. GENE’s portfolio, up 65.71% YTD, held on to second place, while BIOMAV’s portfolio, up 52.11% YTD, jumped into third place with CELGZ’s leap outweighing DVAX’s damage. At Friday's close, 7 of the 38 Contest portfolios were now in the red, with just 12 of the 38 portfolios beating the NBI. Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks ranked by % Gained and % Lost for the week. (Foreign stock prices are not converted to US$ in the weekly and YTD Top 5 & Bottom 5 tables, when posted.) Portfolio adjustments: None. Have a relaxing weekend biotechies! (All corrections, especially adjustments for splits, greatly appreciated.) 11/16/12 Rank Name Profit/Loss 1 RKRW 116,731 2 GENE 65,712 3 BIOMAV 52,113 4 BULBA 50,086 5 TNSAF 47,344 6 ANON 41,028 7 DOUGH 40,513 8 PGO 40,086 9 BIOJIM 39,796 10 DONS 39,108 Week's Top 5 Gainers Symbol 11/9 11/16 Wk.%chg. PYMX 0.09 0.22 142.16% CELGZ 3.11 5.97 91.84% TTNP 0.80 0.93 16.25% CLSN 4.60 5.32 15.65% IDRA 0.69 0.79 14.49% Week's Worst 5 Losers Symbol 11/9 11/16 Wk.%chg. TZYM 4.05 0.80 -80.25% DVAX 4.17 2.44 -41.49% NKTR 8.15 5.99 -26.50% ISR 0.52 0.40 -24.04% KOOL 0.85 0.67 -21.18%